Where 2seventy bio Stands With Analysts
Portfolio Pulse from Benzinga Insights
In the last quarter, 2seventy bio (NASDAQ:TSVT) received three somewhat bullish ratings and one indifferent rating from analysts. The company's average price target is $22.5, a decrease of 15.09% from the previous average price target of $26.50.
July 28, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
2seventy bio received mostly somewhat bullish ratings from analysts, but its average price target has decreased.
The somewhat bullish ratings indicate that analysts have a generally positive view of 2seventy bio. However, the decrease in the average price target could suggest that they have lowered their expectations for the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100